Cure My Disease

Don't miss your cure!

 Log in / Sign up

Male birth control pill enters human testing

NCT ID NCT06542237

Recruiting now Disease control Sponsor: YourChoice Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new daily pill called YCT-529 for male contraception. It involves 88 healthy men who have decided not to have children. The pill is taken for 28, 90, or 180 days to check its safety, side effects, and how well it works. This is an early step toward giving men a daily birth control option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
YCT-529 (a daily oral pill for male contraception)
What this could lead to
If successful, this could lead to a new, non-hormonal daily birth control pill for men, giving couples more options.
What could go wrong
This is an early-phase trial with only 88 men, so it may not prove safe or effective enough. Side effects or lack of reliable contraception are possible risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALE CONTRACEPTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple endocrine neoplasia type 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALE CONTRACEPTION

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • New Zealand Clinical Research (NZCR)

    RECRUITING

    Grafton, Auckland, 1010, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.